Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Pharmaceutical Technology® sat down with Adam Sherlock, CEO of Qinecsa, to discuss the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Posdinemab is the second tau-directed investigational therapy by J&J that has received fast track designation from FDA this year for Alzheimer’s disease. The final guidance is a revision of a policy ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...